● Recruiting

Reduced Vaccine Response to HZ/su in SLE

Condition: Vaccine Reaction · Zoster · Systemic Lupus Erythematosus · Sponsor: Seoul National University Hospital

PhaseN/A

Planned participants80

Who can joinAll sexes, 50 Years to no upper limit

Healthy volunteersYes

About this study

The goal of this observational study is to compare the vaccine response to the 2 doses of the adjuvanted herpes zoster subunit vaccine(HZ/su, "Shingrix") in patients with SLE and the age-, sex-, ethnicity-matched controls without autoimmune disease.

This description comes directly from the study's public registry record.

Talk to the study team

Jin Kyun Park, MD · 82-2-2072-4765 · jinkyunpark@snu.ac.kr

Always discuss trial participation with your own doctor first.

Locations (1)

Seoul National University Hospital

Seoul, South Korea

Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07636044